The DOI matches its Crossref record; 102 of the 106 references it cites were found in a registry or an index.
The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system
Open accessAbstract
In 2019-2020 a new coronavirus named SARS-CoV-2 was identified as the causative agent of a several acute respiratory infection named COVID-19, which is causing a worldwide pandemic. There are still many unresolved questions regarding the pathogenesis of this disease and especially the reasons underlying the extremely different clinical course, ranging from asymptomatic forms to severe manifestations, including the Acute Respiratory Distress Syndrome (ARDS). SARS-CoV-2 showed phylogenetic similarities to both SARS-CoV and MERS-CoV viruses, and some of the clinical features are shared between COVID-19 and previously identified beta-coronavirus infections. Available evidence indicate that the so called "cytokine storm" an uncontrolled over-production of soluble markers of inflammation which, in turn, sustain an aberrant systemic inflammatory response, is a major responsible for the occurrence of ARDS. Chemokines are low molecular weight proteins with powerful chemoattractant activity which play a role in the immune cell recruitment during inflammation. This review will be aimed at providing an overview of the current knowledge on the involvement of the chemokine/chemokine-receptor system in the cytokine storm related to SARS-CoV-2 infection. Basic and clinical evidences obtained from previous SARS and MERS epidemics and available data from COVID-19 will be taken into account.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“T helper (Th)-1 cytokines, including Interleukin (IL)-1β, IL-6, Interferon (IFN)-γ, Tumor Necrosis Factor (TNF)-α, CXCL10, and CCL2; and Th-2 cytokines, including IL-4, IL-10, and IL-1 receptor antagonist are all elevated in the serum of COVID-19 patients (Coperchini et al., 2020) in a “cytokine storm” typically associated with the illness.”
From Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up (2021) · cites this paper as Coperchini et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,332
Lauer, S. A., Grantz, K. H., Bi, Q., Jones, F. K., Zheng, Q., Meredith, H. R., Azman, A. S., Reich, N. G., & Lessler, J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0504 · Cited by 5,970
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,677
Clinical and immunological features of severe and moderate coronavirus disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532
Coronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,910
The reproductive number of COVID-19 is higher compared to SARS coronavirus
Liu, Y., Gayle, A. A., Wilder‐Smith, A., & Rocklöv, J. (2020) · Journal of Travel Medicine · doi:10.1093/jtm/taaa021 · Cited by 3,243
Cited by
Sorted by citations
Items 301–400 of 1,000
COVID-19: imbalanced cell-mediated immune response drives to immunopathology
Wang, J., Li, Q., Qiu, Y., & Lu, H. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2122579 · Cited by 36
Macrophage responses associated with COVID-19: A pharmacological perspective
Booz, G. W., Altara, R., Eid, A. H., Wehbe, Z., Fares, S. A., Zaraket, H., Habeichi, N. J., & Zouein, F. A. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173547 · Cited by 38
Martínez‐Fierro, M. L., Ríos-Jasso, J., Veloz, I. G., Reyes-Veyna, L., Cerda-Luna, R. M., Duque-Jara, I., Galvan-Jimenez, M., Ramírez-Hernández, L. A., Morales-Esquivel, A., Ortiz‐Castro, Y., et al. (2020) · American Journal of Infection Control · doi:10.1016/j.ajic.2020.10.002 · Cited by 36
Assessment of Galectin-1, Galectin-3, and Prostaglandin E2 Levels in Patients with COVID-19
Kazancıoğlu, S., Yılmaz, F. M., Baştuğ, A., Özbay, B. O., Aydos, Ö., Yücel, Ç., Bodur, H., & Yılmaz, G. (2021) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2021.020 · Cited by 35
Gyebi, G. A., Ogunyemi, O. M., Ibrahim, I. M., Afolabi, S. O., & Adebayo, J. O. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104406 · Cited by 35
Cerqueira, S. R. P. S., Deps, P. D., Cunha, D. V., Bezerra, N. V. F., Barroso, D. H., Pinheiro, A. B. S., Pileggi, G. S., Repsold, T. A. R., Kurizky, P. S., Collin, S. M., et al. (2021) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0009635 · Cited by 35
Low free-T3 serum levels and prognosis of COVID-19: systematic review and meta-analysis
Llamas, M., Garo, M. L., & Giovanella, L. (2021) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2021-0805 · Cited by 35
The Role of Nutrients in Prevention, Treatment and Post-Coronavirus Disease-2019 (COVID-19)
Motti, M. L., Tafuri, D., Donini, L. M., Masucci, M. T., Falco, V. D., & Mazzeo, F. (2022) · Nutrients · doi:10.3390/nu14051000 · Cited by 35
Nicoletti, A. D. S., Visacri, M. B., da Ronda, C. R. D. S. C., Vasconcelos, P. E. N. S., Quintanilha, J. C. F., de Souza, R. N., Ventura, D. D. S., Eguti, A., Silva, L. F. D. S., Perroud, M. W., et al. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07338-9 · Cited by 36
Harrell, C. R., Jovicic, B. P., Djonov, V., & Volarević, V. (2020) · Analytical Cellular Pathology · doi:10.1155/2020/1939768 · Cited by 35
Drug targets, mechanisms of drug action, and therapeutics against SARS-CoV-2
Jena, N. R. (2021) · Chemical Physics Impact · doi:10.1016/j.chphi.2021.100011 · Cited by 34
Review on therapeutic targets for COVID-19: insights from cytokine storm
Júnior, M. L. D. M. S., de Souza, L. M. A., Dutra, R. E. M. C., Valente, R. G. D. M., & Melo, T. S. (2020) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2020-138791 · Cited by 34
Potential inhibitors of SARS-CoV-2: recent advances
Soufi, G. J., & Iravani, S. (2020) · Journal of drug targeting · doi:10.1080/1061186x.2020.1853736 · Cited by 33
SARS CoV2 infection _The longevity study perspectives
Lio, D., Scola, L., Giarratana, R. M., Candore, G., Colonna‐Romano, G., Caruso, C., & Balistreri, C. R. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101299 · Cited by 33
Rationales and uncertainties for aspirin use in COVID-19: a narrative review
Ahmed, H. A. S., Merrell, E., Ismail, M., Joudeh, A. I., Riley, J. B., Shawkat, A., Habeb, H., Darling, E., Goweda, R. A., Shehata, M. H., et al. (2021) · Family Medicine and Community Health · doi:10.1136/fmch-2020-000741 · Cited by 33
Modulation of ACE-2 mRNA by inflammatory cytokines in human thyroid cells: a pilot study
Coperchini, F., Ricci, G., Croce, L., Denegri, M., Ruggiero, R., Villani, L., Magri, F., Chiovato, L., & Rotondi, M. (2021) · Endocrine · doi:10.1007/s12020-021-02807-w · Cited by 35
Self-citationQamar, S. U. R. (2021) · Colloids and Interface Science Communications · doi:10.1016/j.colcom.2021.100463 · Cited by 33
A Validated Mathematical Model of the Cytokine Release Syndrome in Severe COVID-19
Reis, R. F., Pigozzo, A. B., Bonin, C. R. B., Quintela, B. D. M., Pompei, L. T., Vieira, A. C., Silva, L. D. L. E., Xavier, M. P., dos Santos, R. W., & Lobosco, M. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.639423 · Cited by 34
Visacri, M. B., Nicoletti, A. D. S., Pincinato, E. D. C., Loren, P., Saavedra, N., Saavedra, K., Salazar, L. A., & Moriel, P. (2021) · Biomarkers in Medicine · doi:10.2217/bmm-2021-0348 · Cited by 33
Arnardottir, H. H., Pawelzik, S., Sarajlic, P., Quaranta, A., Kolmert, J., Religa, D., Wheelock, C. E., & Bäck, M. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.895 · Cited by 33
Wang, Y., Luu, L. D. W., Liu, S., Zhu, X., Huang, S., Li, F., Huang, X., Guo, L., Zhang, J., Ge, H., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01641-y · Cited by 35
Russo, R. C., & Ryffel, B. (2024) · Cells · doi:10.3390/cells13242058 · Cited by 35
Neurological Consequences of 2019-nCoV Infection: A Comprehensive Literature Review
Azim, D., Nasim, S., Kumar, S., Hussain, A., & Patel, S. (2020) · Cureus · doi:10.7759/cureus.8790 · Cited by 33
Jia, S., Luo, H., Liu, X., Fan, X., Huang, Z., Lu, S., Shen, L., Guo, S., Liu, Y., Wang, Z., et al. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113871 · Cited by 32
Alfarouk, K. O., Alhoufie, S. T. S., Hifny, A., Schwartz, L. H., Alqahtani, A. S., Ahmed, S. B. M., Alqahtani, A., Alqahtani, S. S., Muddathir, A. K., Ali, H. S., et al. (2021) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2021.1937144 · Cited by 32
MiRNA Profiling in Plasma and Placenta of SARS-CoV-2-Infected Pregnant Women
Saulle, I., Garziano, M., Fenizia, C., Cappelletti, G., Parisi, F., Clerici, M., Cetin, I., Savasi, V., & Biasin, M. (2021) · Cells · doi:10.3390/cells10071788 · Cited by 30
Zhu, Z., Wang, M., Lin, W. S., Cai, Q., Zhang, L., Chen, D., Liu, F., Xiong, X., Chu, J., Peng, J., et al. (2021) · Immunity Inflammation and Disease · doi:10.1002/iid3.471 · Cited by 32
Cytokine storm in the pathophysiology of COVID-19: Possible functional disturbances of miRNAs
Aslani, M., Mortazavi‐Jahromi, S. S., & Mirshafiey, A. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108172 · Cited by 31
Shambat, S. M., Gómez-Mejía, A., Schweizer, T. A., Huemer, M., Chang, C., Acevedo, C., Bergadà-Pijuan, J., Vulin, C., Hofmaenner, D. A., Scheier, T., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010176 · Cited by 34
Vásquez, V., & Orozco, J. (2022) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-022-04237-7 · Cited by 32
Conceptions of the pathophysiology of happy hypoxemia in COVID-19
Dhont, S., Derom, E., Braeckel, E. V., Depuydt, P. O., & Lambrecht, B. N. (2021) · Respiratory Research · doi:10.1186/s12931-021-01614-1 · Cited by 32
Vitiello, A., Porta, R. L., & Ferrara, F. (2021) · Medical Hypotheses · doi:10.1016/j.mehy.2021.110486 · Cited by 31
Baharudin, N., Al-Bayaty, F. H., & Hassan, M. I. A. (2021) · Dental and Medical Problems · doi:10.17219/dmp/132979 · Cited by 31
Homeostatic chemokines as putative therapeutic targets in idiopathic pulmonary fibrosis
Russo, R. C., Quesniaux, V. F. J., & Ryffel, B. (2023) · Trends in Immunology · doi:10.1016/j.it.2023.10.003 · Cited by 32
Gorini, F., Chatzianagnostou, K., Mazzone, A., Bustaffa, E., Esposito, A., Berti, S. L., Bianchi, F., & Vassalle, C. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17207371 · Cited by 31
Tzachor, A., Rozen, O., Khatib, S., Jensen, S., & Avni, D. (2021) · Marine Biotechnology · doi:10.1007/s10126-021-10020-z · Cited by 31
Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19
Touyz, R. M., Boyd, M. O. E., Guzik, T. J., Padmanabhan, S., McCallum, L., Delles, C., Mark, P. B., Petrie, J. R., Rios, F. J. O., Montezano, A. C. I., et al. (2021) · CJC Open · doi:10.1016/j.cjco.2021.05.020 · Cited by 34
Sahebnasagh, A., Nabavi, S. M., Kashani, H. R. K., Aghaabdollahian, S., Habtemariam, S., & Rezabakhsh, A. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108257 · Cited by 31
Rommasi, F., Nasiri, M. J., & Mirsaeidi, M. S. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04325-9 · Cited by 31
Ekinci, A. P., Pehlivan, G., & Gökalp, M. O. (2020) · Dermatologic Therapy · doi:10.1111/dth.14700 · Cited by 30
Ghodake, G. S., Shinde, S. K., Kadam, A. A., Saratale, R. G., Saratale, G. D., Syed, A., Elgorban, A. M., Marraiki, N., & Kim, D.-Y. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.112969 · Cited by 31
Sukkar, S. G., Cogorno, L., Pisciotta, L., Pasta, A., Vena, A., Gradaschi, R., Dentone, C., Guiddo, E., Martino, E., Beltramini, S., et al. (2021) · Nutrition · doi:10.1016/j.nut.2021.111236 · Cited by 30
Not so sweet and simple: impacts of SARS-CoV-2 on the β cell
Ibrahim, S., Monaco, G. S. F., & Sims, E. K. (2021) · Islets · doi:10.1080/19382014.2021.1909970 · Cited by 30
Balzanelli, M. G., Distratis, P., Dipalma, G., Vimercati, L., Catucci, O., Amatulli, F., Cefalo, A., Lazzaro, R., Palazzo, D., Aityan, S. K., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9102036 · Cited by 32
COVID-19 inflammation and implications in drug delivery
Zoulikha, M., Huang, F., Wu, Z., & He, W. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.04.027 · Cited by 32
Mittal, R., Chourasia, N., Bharti, V. K., Singh, S., Sarkar, P., Agrawal, A., Ghosh, A., Pal, R., Kanwar, J. R., & Kotnis, A. L. (2022) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_2283_21 · Cited by 32
Giménez, V. M. M., Heras, N. D. L., Ferder, L., Lahera, V., Reiter, R. J., & Manucha, W. A. (2021) · Diseases · doi:10.3390/diseases9020030 · Cited by 30
Umakanthan, S., Senthil, S., John, S., Madhavan, M. K., Das, J., Patil, S., Rameshwaram, R., Cintham, A., Subramaniam, V., Yogi, M., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.742273 · Cited by 29
Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome
Azar, M. M., Shin, J. J., Kang, I., & Landry, M. L. (2020) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2020.1830760 · Cited by 30
Perspective Adjunctive Therapies for COVID-19: Beyond Antiviral Therapy
Ho, P., Zheng, J.-Q., Wu, C., Hou, Y., Liu, W.-C., Lu, C., Zheng, C., Lu, K., & Chao, Y. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.51935 · Cited by 29
Kalpakçı, Y., Hacıbekiroğlu, T., Gülay, T. R. A. K., Karacaer, C., Demirci, T., Kocayiğit, H., Sunu, C., Varım, C., & Falay, M. (2020) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.66.12.1666 · Cited by 29
Ramos-Peñafiel, C. O., Santos-González, B., Flores-López, E. N., Galván-Flores, F., Hernández-Vázquez, L., Santoyo-Sánchez, A., de Oca-Yemha, R. M., Bejarano-Rosales, M., Rosas-González, Ó., Olarte-Carrillo, I., et al. (2020) · Gaceta Médica de México · doi:10.24875/gmm.m20000428 · Cited by 29
Eskandarani, R., & Sawan, S. (2020) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/1179551420984125 · Cited by 29
Nijman, G., Wientjes, M. H. M., Ramjith, J., Janssen, N. A. F., Hoogerwerf, J. J., Abbink, E. J., Blaauw, M. J. T., Dofferhoff, T., van Apeldoorn, M., Veerman, K. M., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0249231 · Cited by 29
Ali, F. E. M., Mohammedsaleh, Z. M., Ali, M., & Ghogar, O. M. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i15.1531 · Cited by 29
Unraveling the molecular crosstalk between Atherosclerosis and COVID-19 comorbidity
Das, D., & Podder, S. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104459 · Cited by 29
Kaliamurthi, S., Selvaraj, G., Selvaraj, C., Singh, S. K., Wei, D., & Peslherbe, G. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137071 · Cited by 29
Automated Machine Learning Optimizes and Accelerates COVID-19 Predictive Modeling
Παπουτσόγλου, Γ., Karaglani, M., Lagani, V., Thomson, N., Røe, O. D., Tsamardinos, I., & Chatzaki, Ε. (2021) · Scientific Reports · doi:10.1038/s41598-021-94501-0 · Cited by 29
Omran, D., Soda, M. F. A., Bahbah, E. I., Esmat, G., Shousha, H. I., Elgebaly, A. S., Ghaffar, M. A., Alsheikh, M., Sayed, E. E., Afify, S., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256203 · Cited by 29
A New Butyrate Releaser Exerts a Protective Action against SARS-CoV-2 Infection in Human Intestine
Paparo, L., Maglio, M. A., Cortese, M., Bruno, C., Capasso, M., Punzo, E., Ferrucci, V., Lasorsa, V. A., Viscardi, M., Fusco, G., et al. (2022) · Molecules · doi:10.3390/molecules27030862 · Cited by 30
Jónsdóttir, H. R., Siegrist, D., Julien, T., Padey, B., Bouveret, M., Terrier, O., Pizzorno, A., Huang, S., Samby, K., Wells, T. N. C., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113058 · Cited by 31
Mundula, T., Russo, E., Curini, L., Giudici, F., Piccioni, A., Franceschi, F., & Amedei, A. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220430131018 · Cited by 29
The effects of selenium supplementation on inflammatory markers in critically ill patients
Mahmoodpoor, A., Faramarzi, E., Reyhanifard, A., Shamekh, A., Nikanfar, S., Azizi-Zeinalhajlou, A., & Sanaie, S. (2022) · SN Applied Sciences · doi:10.1007/s42452-022-05208-4 · Cited by 29
D’Ávila, H., Lima, C. N. R., Rampinelli, P. G., Mateus, L. C. O., Silva, R. V. D. S., Corrêa, J. R., & de Almeida, P. E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25010640 · Cited by 29
Tan, Y., Zhang, W., Zhu, Z., Qiao, N., Ling, Y., Guo, M., Tong, Y., Fang, H., Xu, X., Lü, G., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00274-1 · Cited by 29
“Fei Yan No. 1” as a Combined Treatment for COVID-19: An Efficacy and Potential Mechanistic Study
Zhong-zhu, A., Zhou, S., Li, W., Wang, M., Wang, L., Hu, G., Tao, R., Wang, X., Shen, Y., Xie, L., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.581277 · Cited by 28
Combating the Pandemic COVID-19: Clinical Trials, Therapies and Perspectives
Kotta, S., Aldawsari, H. M., Badr-Eldin, S. M., Alhakamy, N. A., Md, S., Nair, A. B., & Deb, P. K. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.606393 · Cited by 28
COVID-19-associated secondary hemophagocytic lymphohistiocytosis (cytokine storm syndrome)
Alexeeva, E. I., Фаридович, Т. Р., Shilkrot, I. Y., Dvoryakovskaya, T. M., Surkov, A. G., & Kriulin, I. A. (2021) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn1410 · Cited by 29
Gauthier, A. G., Lin, M., Wu, J., Kennedy, T. P., Daley, L.-A., Ashby, C. R., & Mantell, L. L. (2021) · Journal of Immunotoxicology · doi:10.1080/1547691x.2021.1875085 · Cited by 28
Edible and Herbal Plants for the Prevention and Management of COVID-19
Li, S., Cheng, C., Zhang, C., Tang, G., Tan, H., Chen, H., Wang, N., Lai, A. Y. K., & Feng, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.656103 · Cited by 28
Du, X., Shi, L., Cao, W., Chen, Z., Zuo, B., & Hu, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.708636 · Cited by 28
Goswami, R., Russell, V. S., Tu, J. J., Thomas, C., Hughes, P. F., Kelly, F. L., Langel, S. N., Steppe, J. T., Palmer, S. M., Haystead, T., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103412 · Cited by 28
Euthyroid sick syndrome as an early surrogate marker of poor outcome in mild SARS-CoV-2 disease
Sparano, C., Zago, E., Morettini, A., Nozzoli, C., Yannas, D., Adornato, V., Caldini, E., Vaudo, M., Maggi, M., & Petrone, L. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01714-1 · Cited by 28
Increased Expression of Tim-3 Is Associated With Depletion of NKT Cells In SARS-CoV-2 Infection
Yang, J., Chang, T., Tang, L., Deng, H., Chen, D., Luo, J., Wu, H., Tang, T.-X., Zhang, C., Li, Z., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.796682 · Cited by 28
A robust and parsimonious machine learning method to predict ICU admission of COVID-19 patients
Famiglini, L., Campagner, A., Carobene, A., & Cabitza, F. (2022) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-022-02543-x · Cited by 28
Palladini, M., Bravi, B., Colombo, F., Caselani, E., Pasquasio, C. D., D'Orsi, G., Rovere, P. Q., Poletti, S., Benedetti, F., & Mazza, M. G. (2022) · Neuropsychological Rehabilitation · doi:10.1080/09602011.2022.2075016 · Cited by 32
Karu, N., Kindt, A. S. D., van Gammeren, A. J., Ermens, A. A. M., Harms, A. C., Portengen, L., Vermeulen, R. C. H., Dik, W. A., Langerak, A. W., van der Velden, V. H. J., et al. (2022) · Metabolites · doi:10.3390/metabo12070618 · Cited by 29
Lung development and regeneration: newly defined cell types and progenitor status
Meng, X., Cui, G., & Peng, G. (2023) · Cell Regeneration · doi:10.1186/s13619-022-00149-0 · Cited by 28
The miRNA neuroinflammatory biomarkers in COVID-19 patients with different severity of illness
Keikha, R., Hashemi‐Shahri, S. M., & Jebali, A. (2021) · Neurología · doi:10.1016/j.nrl.2021.06.005 · Cited by 29
Li, A., Ling, Y., Song, Z., Cheng, X., Ding, L., Jiang, R.-D., Fu, W., Liu, Y., Hu, H., Yuan, S., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa713 · Cited by 27
COVID-19 in Children With Liver Disease
Giorgio, A. D., Hartleif, S., Warner, S., & Kelly, D. A. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.616381 · Cited by 27
Patel, S., & Wadhwa, M. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111785 · Cited by 27
He, L., Zhang, Q., Zhang, Y., Fan, Y., Yuan, F., & Li, S. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00754-7 · Cited by 27
Karampoor, S., Hesamizadeh, K., Maleki, F., Farahmand, M., Zahednasab, H., Mirzaei, R., Banoun, H., Zamani, F., Hajibaba, M., Tabibzadeh, A., et al. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108137 · Cited by 27
What Happens to the Immune System after Vaccination or Recovery from COVID-19?
Tiyo, B. T., Schmitz, G. J. H., Ortega, M. M., da Silva, L. T., de Almeida, A., Oshiro, T. M., & Duarte, A. J. D. S. (2021) · Life · doi:10.3390/life11111152 · Cited by 28
Choe, K., Park, H. Y., Ikram, M. A., Lee, H. J., Park, T. J., Ullah, R., & Kim, M.-O. (2022) · Cells · doi:10.3390/cells11081298 · Cited by 28
Reactive Sulfur Compounds in the Fight against COVID-19
Iciek, M., Bilska‐Wilkosz, A., Kozdrowicki, M., & Górny, M. (2022) · Antioxidants · doi:10.3390/antiox11061053 · Cited by 27
The striking mimics between COVID-19 and malaria: A review
Konozy, E. H. E., Osman, M. E. M., Ghartey‐Kwansah, G., & Abushama, H. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.957913 · Cited by 27
Quarleri, J. F., & Delpino, M. V. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.01.003 · Cited by 27
Clinical, cerebrospinal fluid and neuroimaging findings in COVID-19 encephalopathy: a case series
Tuma, R., Guedes, B., Carra, R., Iepsen, B., Rodrigues, J., Camelo-Filho, A. E., Kubota, G., Ferrari, M., Neto, A. S., Oku, M. H. M., et al. (2020) · doi:10.1101/2020.08.28.20181883 · Cited by 26
Implications of COVID-19 pandemic on lung cancer management: A multidisciplinary perspective
Bakhribah, H., Zeitouni, M., Daghistani, R. A., Al-Maghraby, H., Khankan, A. A., AlKattan, K. M., Alshehri, S., & Jazieh, A. R. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103120 · Cited by 26
Severe acute myopathy following SARS-CoV-2 infection: a case report and review of recent literature
Islam, B., Ahmed, M., Islam, Z., & Begum, S. (2021) · Skeletal Muscle · doi:10.1186/s13395-021-00266-5 · Cited by 26
Potency of Mesenchymal Stem Cell and Its Secretome in Treating COVID-19
Chouw, A., Milanda, T., Sartika, C. R., Kirana, M. N., Halim, D., & Faried, A. (2021) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-021-00202-5 · Cited by 26
Modulation of Host Immune Response Is an Alternative Strategy to Combat SARS-CoV-2 Pathogenesis
Singh, L., Bajaj, S., Gadewar, M. M., Verma, N., Ansari, M. N., Saeedan, A. S., Kaithwas, G., & Singh, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.660632 · Cited by 26
SARS-CoV2 Infection Alters Tryptophan Catabolism and Phospholipid Metabolism
Kaur, G., Ji, X., & Rahman, I. (2021) · Metabolites · doi:10.3390/metabo11100659 · Cited by 26
The Potential Role of Cytokine Storm Pathway in the Clinical Course of Viral Respiratory Pandemic
Murdaca, G., Paladin, F., Tonacci, A., Isola, S., Allegra, A., & Gangemi, S. (2021) · Biomedicines · doi:10.3390/biomedicines9111688 · Cited by 28
Interlandi, M., Kerl, K., & Dugas, M. (2022) · Communications Biology · doi:10.1038/s42003-021-02986-2 · Cited by 26
Golden, J. W., Li, R., Cline, C. R., Zeng, X., Mucker, E. M., Fuentes-Lao, A. J., Spik, K. W., Williams, J. A., Twenhafel, N. A., Davis, N., et al. (2022) · mBio · doi:10.1128/mbio.02906-21 · Cited by 27
Aspirin in COVID-19: Pros and Cons
Zareef, R. O., Diab, M. M., Saleh, T. A., Makarem, A., Younis, N. K., Bitar, F. F., & Arabi, M. T. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.849628 · Cited by 26
Effects and Causes of Detraining in Athletes Due to COVID-19: A Review
Córdova, A., Caballero-García, A., Roche, E., Pérez-Valdecantos, D., & Noriega, D. C. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19095400 · Cited by 30
Metadata
- Authors
- Coperchini, F., Chiovato, L., Croce, L., Magri, F., & Rotondi, M.
- Affiliations
- Istituti Clinici Scientifici Maugeri (IT)
- University of Pavia (IT)
- Corresponding author
- Rotondi, Mario
- Venue
- Cytokine & Growth Factor Reviews
- Publisher
- Elsevier BV
- Published
- 2020-06
- Volume
- 53
- Pages
- 25-32
- ISSN
- 1359-6101 (ISSN-L)
- PMC
- PMC7211650
- OpenAlex
- W3021577619
- Cited by
- 1,288
- References
- 106
- Citations by year
- 2026: 20 · 2025: 44 · 2024: 92 · 2023: 158 · 2022: 274 · 2021: 443 · 2020: 257
- FWCI
- 13.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cytokine & Growth Factor Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Keywords
- cytokine storm, COVID-19 pandemic, SARS-CoV-2, chemokines, chemokine receptors, acute respiratory distress syndrome, systemic inflammation, immune cell recruitment, SARS, MERS, betacoronaviruses, disease severity
- MeSH terms
- Betacoronavirus, Cytokine Release Syndrome, COVID-19, SARS-CoV-2, Humans, Pneumonia, Viral, Coronavirus Infections, Chemokines, Receptors, Chemokine, Severe Acute Respiratory Syndrome, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
